Your browser doesn't support javascript.
loading
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.
Murray, Julia; Cruickshank, Clare; Bird, Thomas; Bell, Philip; Braun, John; Chuter, Dave; Ferreira, Miguel Reis; Griffin, Clare; Hassan, Shama; Hujairi, Nabil; Melcher, Alan; Miles, Elizabeth; Naismith, Olivia; Panades, Miguel; Philipps, Lara; Reid, Alison; Rekowski, Jan; Sankey, Pete; Staffurth, John; Syndikus, Isabel; Tree, Alison; Wilkins, Anna; Hall, Emma.
Afiliación
  • Murray J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Cruickshank C; The Institute of Cancer Research, London, UK.
  • Bird T; The Institute of Cancer Research, London, UK.
  • Bell P; University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK.
  • Braun J; NCRI Consumer Forum, London, UK.
  • Chuter D; RMH Radiotherapy Focus Group & RMH Biomedical Research Centre Consumer Group, Sutton, UK.
  • Ferreira MR; NCRI Consumer Forum, London, UK.
  • Griffin C; NCRI Living With & Beyond Cancer (Acute and Toxicities Workstream), London, UK.
  • Hassan S; Guys & St Thomas NHS Trust and King's College, London, UK.
  • Hujairi N; The Institute of Cancer Research, London, UK.
  • Melcher A; The Institute of Cancer Research, London, UK.
  • Miles E; The Royal Marsden NHS Foundation Trust, London, UK.
  • Naismith O; The Royal Marsden NHS Foundation Trust, London, UK.
  • Panades M; The Institute of Cancer Research, London, UK.
  • Philipps L; Radiotherapy Trials QA Group (RTTQA), Mount Vernon Hospital, Northwood, UK.
  • Reid A; Radiotherapy Trials QA Group (RTTQA), Royal Marsden NHS Foundation Trust, London, UK.
  • Rekowski J; United Lincolnshire Hospitals NHS Trust, Lincoln, UK.
  • Sankey P; The Royal Marsden NHS Foundation Trust, London, UK.
  • Staffurth J; The Institute of Cancer Research, London, UK.
  • Syndikus I; The Royal Marsden NHS Foundation Trust, London, UK.
  • Tree A; The Institute of Cancer Research, London, UK.
  • Wilkins A; University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Hall E; Velindre University NHS Trust and Cardiff University, Cardiff, UK.
Clin Transl Radiat Oncol ; 37: 130-136, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36238579
PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral interspace) can improve outcomes for this patient group.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda